Helsinn is a privately owned pharmaceutical group with headquarters in Lugano, Switzerland and premises in Ireland and USA. The Helsinn Group has been built on the basis of a unique business model, focused on the in- and out-licensing of pharmaceuticals and medical devices in therapeutic niche areas…
Helsinn is a privately owned pharmaceutical group with headquarters in Lugano, Switzerland and premises in Ireland and USA. The Helsinn Group has been built on the basis of a unique business model, focused on the in- and out-licensing of pharmaceuticals and medical devices in therapeutic niche areas. Helsinn is an important player in Cancer Supportive Care Helsinn in-licenses early to late stage new chemical entities, completes their development from the performance of preclinical and clinical studies and of chemistry, manufacturing and control (CMC) development, to the attainment of their market approval worldwide. Then, the Group markets directly through its network of selected local pharmaceutical partners, selected for their deep in-market knowledge and know-how, and assisted and supported with a full range of product and scientific management services. The active pharmaceutical ingredients and the finished dosage forms are manufactured at Helsinn's cGMP, ISO 14001 and OHSAS 18001 certified facilities in Switzerland and Ireland, and supplied worldwide to its customers.
Team (1)
Join Axial's Private M&A Platform
Helsinn Therapeutics connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.
